Trial Profile
Randomized, Double-blind, Split-body, Placebo-controlled Phase Ib Study of APN201 (Liposomal Recombinant Human Cu/Zn-superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Superoxide dismutase (Primary)
- Indications Radiation-induced skin damage
- Focus Adverse reactions
- Sponsors Apeiron Biologics
- 28 Apr 2014 New trial record